烧伤患者肾功能增强:发生率及其与常用肾功能评估方法的不一致
这项回顾性研究在68例热烧伤患者中收集了163次12小时尿肌酐清除率(CrCl-12)结果,ARC定义为CrCl-12>130 ml/min。ARC患病率为70.6%,所有评估中发生率为66.3%;Cockcroft-Gault、MDRD和CKD-EPI-2021与CrCl-12的一致性为中至弱,且常未能识别ARC。
要点
- 烧伤患者中ARC常见,患病率70.6%,所有CrCl-12评估中发生率66.3%。
- TBSA≥20%、<20%、<10%者的ARC发生率分别为70.5%、58.6%、76.7%。
- Cockcroft-Gault、MDRD和CKD-EPI-2021与CrCl-12一致性中至弱,常漏诊ARC。
核心结论
- ARC在烧伤患者中常见,且与TBSA%无关。
- 广泛接受的肾功能估计方法可能不准确,导致药物剂量不足。
- 需要进一步研究以识别ARC风险最高的烧伤患者及后续给药策略,以维持药效而不致毒性。
研究设计与样本
- 回顾性研究,纳入美国烧伤协会认证烧伤中心所有有CrCl-12结果的热烧伤患者。
- 共68例患者,13个月内收集163次CrCl-12结果,入院至检测中位时间9天。
- ARC定义为CrCl-12>130 ml/min,并计算Cockcroft-Gault、MDRD和CKD-EPI-2021估计值。
主要发现
- CrCl-12平均值为160 ml/min,TBSA%中位数为17.25%。
- ARC患病率为70.6%,所有CrCl-12评估中发生率为66.3%。
- ARC患者较少合并心力衰竭,P=.007;年龄、TBSA%和创伤在有无ARC组间无差异。
- TBSA≥20%、<20%、<10%者的ARC发生率分别为70.5%、58.6%、76.7%。
- Cockcroft-Gault、MDRD和CKD-EPI-2021与CrCl-12的一致性为中至弱,且常未能识别ARC。
关键数值与推荐
- ARC定义为CrCl-12>130 ml/min。
- ARC患病率70.6%,所有CrCl-12评估中发生率66.3%。
- TBSA≥20%者ARC发生率70.5%,<20%者58.6%,<10%者76.7%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Augmented renal clearance (ARC) is defined by supraphysiologic renal function and is associated with drug failure due to subtherapeutic drug exposure. Burn patients are cited as being at high risk for ARC, yet rates of ARC have not been well described. This retrospective study described the prevalence and incidence of ARC, and compared 12-hour urine collection values (CrCl-12) vs. common estimates of renal function in assessed patients at an American Burn Association-verified burn center. All thermally injured burn patients with a CrCl-12 result were included. ARC was defined as a CrCl-12 >130 ml/min. Cockcroft-Gault, modification of diet in renal disease (MDRD), and CKD-EPI-2021 estimates were calculated. Over 13 months, 163 CrCl-12 results were collected in 68 patients at a median of 9 days from admission with an average value of 160 ml/min. The median total body surface area (total body surface area [TBSA]%) was 17.25%. ARC prevalence was 70.6% with an incidence of 66.3% in all CrCl-12 assessments. Those with ARC were less likely to have heart failure, P = .007. Age, TBSA%, and trauma were not different between those with or without ARC. ARC incidences in those with TBSAs of ≥20%, <20%, or <10%, were 70.5%, 58.6%, and 76.7%, respectively. Agreement of Cockcroft-Gault, MDRD, and CKD-EPI-2021 to CrCl-12 was moderate to weak and frequently failed to identify ARC. ARC is common in burn patients, regardless of TBSA%. Widely accepted estimations of renal function may be incorrect resulting in under-dosing of medications. Additional research is required to identify burn patients at greatest risk for ARC and subsequent dosing strategies to maintain pharmacologic efficacy without unduetoxicity.
引用
- Mueller SW, Blass B, Molina KC, et al. Augmented Renal Function in Burn Patients: Occurrence and Discordance With Commonly Used Methods to Assess Renal Function. J Burn Care Res. 2023. PMID: 37450897. doi:10.1093/jbcr/irad107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。